Health Condition 1: null- CHRONIC LUMBAR RADICULOPATHY
Conditions
Interventions
Control Intervention1: pregabalin , gabapentin , amitriptyline: three groups . group A will be given pregabalin 75 mg bid , group B will be given gabapentin 300 mg bid, group C will be given amitripty
Sponsors
NONE
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patient willing to participate in the study. 2.Age group of 18-65 years of either sex. 3.Diagnosed cases of chronic lumbar radiculopathy based on symptoms, clinical examination, x-ray and MRI scan of lumbosacral spine. 4.Patients who have not taken the study drugs previously.
Exclusion criteria
Exclusion criteria: 1.pregnant and lactating women 2.immunocompromized patients 3.history of diabetes and tuberculosis 4.history of cardiac illness 5.history of renal and liver disease 6.patients taking anticholinergics and antipsychotic medicines 7.history of psychiatric disorders 8.patients having neurodeficit in lower limb 9. patients with bladder and bladder incontinence 10.radiculopathy secondary to tumors 11.patients with known hypersensitivity to trial drugs.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| reduction of intensity of neuropathic painTimepoint: At the end of 6 weeks and 12 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| change in mean pain score from baseline to end pointTimepoint: At the end of 6 weeks and 12 weeks | — |
Countries
India
Contacts
Public ContactDR HUZAIF B SHAIKH
MGMs medical college, Aurangabad
Outcome results
None listed